We are live on ! Find out more
IMMU

Immunomedics Inc
IMMU

Delisted

IMMU was delisted on the 22nd of October, 2020.

85 hedge funds and large institutions have $186M invested in Immunomedics Inc in 2014 Q4 according to their latest regulatory filings, with 16 funds opening new positions, 22 increasing their positions, 22 reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed

60% more first-time investments, than exits

New positions opened: 16 | Existing positions closed: 10

37% more capital invested

Capital invested by funds: $135M → $186M (+$50.6M)

35% more call options, than puts

Call options by funds: $6.76M | Put options by funds: $5M

5% more funds holding

Funds holding: 8185 (+4)

0% more repeat investments, than reductions

Existing positions increased: 22 | Existing positions reduced: 22

Holders
85
Holders Change
+4
Holders Change %
+4.94%
% of All Funds
2.27%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
16
Increased
22
Reduced
22
Closed
10
Calls
$6.76M
Puts
$5M
Net Calls
+$1.76M
Net Calls Change
+$2.35M
Name Holding Trade Value Shares
Change
Change in
Stake
ABI
26
Adamant Biomedical Investments
Switzerland
$720K
TA
27
Teachers Advisors
New York
$654K
CS
28
Credit Suisse
Switzerland
$555K +$300K +75,800 +192%
AllianceBernstein
29
AllianceBernstein
Tennessee
$544K -$25.7K -6,500 -5%
State Board of Administration of Florida Retirement System
30
State Board of Administration of Florida Retirement System
Florida
$494K
D.E. Shaw & Co
31
D.E. Shaw & Co
New York
$487K +$401K +101,378 New
Swiss National Bank
32
Swiss National Bank
Switzerland
$460K
Group One Trading
33
Group One Trading
Illinois
$451K -$246K -62,137 -40%
Barclays
34
Barclays
United Kingdom
$440K +$231K +58,427 +113%
ProShare Advisors
35
ProShare Advisors
Maryland
$381K -$5.5K -1,390 -2%
RhumbLine Advisers
36
RhumbLine Advisers
Massachusetts
$341K +$10.3K +2,600 +4%
Connor, Clark & Lunn Investment Management (CC&L)
37
Connor, Clark & Lunn Investment Management (CC&L)
British Columbia, Canada
$322K +$265K +67,000 New
NFA
38
Nationwide Fund Advisors
Ohio
$303K -$2.75K -696 -1%
VOYA Investment Management
39
VOYA Investment Management
Georgia
$296K
MLICM
40
Metropolitan Life Insurance Company (MetLife)
New York
$295K
Wells Fargo
41
Wells Fargo
California
$276K -$24.1K -6,108 -10%
AIG
42
American International Group
New York
$257K -$8.13K -2,058 -4%
DIA
43
Denver Investment Advisors
Colorado
$253K +$870 +220 +0.4%
Goldman Sachs
44
Goldman Sachs
New York
$244K -$151K -38,116 -43%
BA
45
BlackRock Advisors
Delaware
$239K -$12.1K -3,059 -6%
DekaBank Deutsche Girozentrale
46
DekaBank Deutsche Girozentrale
Germany
$235K -$17.8K -4,500 -8%
Public Employees Retirement Association of Colorado
47
Public Employees Retirement Association of Colorado
Colorado
$231K
Citigroup
48
Citigroup
New York
$220K +$67K +16,952 +59%
CIA
49
Capital Impact Advisors
Massachusetts
$208K
Two Sigma Investments
50
Two Sigma Investments
New York
$197K +$162K +40,975 New

IMMU Hedge Fund Activity: Q4 2014 in Review

85 of the 3,751 institutional investors tracked by Wall St. Rank reported a position in Immunomedics Inc (IMMU) for Q4 2014, worth a combined $186M — up 37% from $135M a quarter earlier.

Buyers outnumbered sellers: 16 funds opened new IMMU positions and 10 closed out — a net gain of 6 holders — while 22 added to existing stakes and 22 trimmed.

The largest buyer was TFS Capital, adding an estimated $2.33M. The largest seller was Sphera Funds Management, exiting entirely with an estimated $1.99M sold.

  • 85 institutional investors held Immunomedics Inc (IMMU) as of Q4 2014, up from 81 in Q3 2014.
  • Funds reported $186M of Immunomedics Inc stock for Q4 2014, up 37% quarter-over-quarter.
  • 16 funds opened new Immunomedics Inc positions in Q4 2014 and 10 closed out, a net change of +6 holders.
  • The largest Immunomedics Inc buyer in Q4 2014 was TFS Capital, an estimated $2.33M added.
  • The largest Immunomedics Inc seller in Q4 2014 was Sphera Funds Management, an estimated $1.99M sold.

Based on aggregated 13F filings for Q4 2014.